OTLK: Outlook Therapeutics, Inc. Stock

by  •  • Comments Off on OTLK: Outlook Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 47.30
Enterprise Value ($M) 69.73
Book Value ($M) -50.29
Book Value / Share -1.54
Price / Book -0.89
NCAV ($M) -51.63
NCAV / Share -1.58
Price / NCAV -0.92

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.79
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.26
Current Ratio 0.32

Balance Sheet (mrq) ($M)
Current Assets 15.67
Assets 17.01
Liabilities 67.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -71.70
Net Income -75.37
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -68.79
Cash from Investing 0.00
Cash from Financing 60.33

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-10 13G/A Sphera Funds Management Ltd. 7.49 50.00
03-12 13D/A GMS Ventures & Investments 41.60 27.18
02-14 13G/A Tang Capital Partners Lp 6.40 -24.07
02-14 13G/A Great Point Partners Llc 8.18 -10.56
11-07 13G/A Velan Capital Investment Management LP 3.10 -40.00
2024-04-17 13D/A Syntone Ventures LLC 11.40 -85.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-01-23 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2024 ☐TRANSITION REPOR
2024-12-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 77,588 278,087 27.90
2025-04-16 99,342 244,061 40.70
2025-04-15 84,604 202,084 41.87

(click for more detail)

Similar Companies
ONVO – Organovo Holdings, Inc. ORGO – Organogenesis Holdings Inc.
ORMP – Oramed Pharmaceuticals Inc. PALI – Palisade Bio, Inc.
PASG – Passage Bio, Inc.


Financial data and stock pages provided by
Fintel.io